Treatment of postherpetic neuralgia: An update

Drugs

Volumn 59, Issue 5, 2000, Pages 1113-1126

  Kanazi, Ghassan E ^a   Johnson, Robert W ^b   Dworkin, Robert H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMITRIPTYLINE; CALCIUM ANTAGONIST; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; DEXTROMETHORPHAN; EMLA; FLECAINIDE; FLUOXETINE; GABAPENTIN; KETAMINE; LEVOMEPROMAZINE; LIDOCAINE; LORAZEPAM; MEMANTINE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; PARACETAMOL; PAROXETINE; PHENYTOIN; TRAMADOL; UNINDEXED DRUG; VENLAFAXINE; VINCRISTINE;

ALLODYNIA; ARACHNOIDITIS; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; HUMAN; NERVE BLOCK; NEUROLOGICAL COMPLICATION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; PAIN CLINIC; POSTHERPETIC NEURALGIA; REVIEW; SEDATION; SOMNOLENCE; SURGICAL APPROACH; VERTIGO;

EID: 0034086342     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059050-00007     Document Type: Review

References (121)

1. 1. Kost RG, Straus SE. Postherpetic neuralgia: pathogenesis, treatment, and prevention, N Engl J Med 1996; 335: 32-42
2. 2. Watson CPN, editor. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993
3. 3. Dworkin RH, Johnson RW. A belt of roses from hell: pain in herpes zoster and postherpetic neuralgia. In: Block AR, Kremer EF, Fernandez E, editors. Handhook of pain syndromes: biopsychosocial perspectives. Hillsdale (NJ): Erlhaum, 1999: 371-402
4. 4. Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes roster. JAMA 1957; 164: 265-9
5. 5. Bamford JAC, Boundy CAP. The natural history of herpes zoster (shingles). Med J Aust 1968; No. 13: 524-8
6. 6. Rogers III RS, Tindall JP. Geriatric herpes zoster. J Am Geriatr Soc 1971; 19:495-504
7. 7. Max MB, Schafer SC, Culmine M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427-32
8. 8. Baron R, Saguer M. Postherpelic neuralgia: are C-nociceptors involved in signalling and maintenance of tactile allodjnia? Brain 1993; 116: 1477-96
9. 9. Dworkin RH, Portenoy RK. Proposed classification of herpes zoster pain. Lancet 1994; 343: 1648
10. 10. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67: 241-51
11. 11. Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis 1991; Suppl. 78: 62-8
12. 12. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546-53
13. 13. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123; 89-96
14. 14. Wood MJ, Kay R, Dworkin RH, et al. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996:22:341-7
15. 15. Jackson JL, Gibbons R, Meyer G, et al. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis. Arch Intern Med 1997; 157: 909-12
16. 16. Dworkin RH, Boon RJ, Griffin DRG, et al. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998; 178 Suppl. 1: S76-80
17. 17. Watson CPN, Watt VR, Chipman M, et al. The prognosis of postherpetic neuralgia. Pain 1991; 46: 195-9
18. 18. Huff JC, Drucker JL, Clemmer A, et al. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol 1993; Suppl. 1:93-6
19. 19. McKendrick MW, Care CD, Ogan P, et al. A retrospective study of the epidemiology of zoster with particular reference to factors pertinent to the development of chronic pain. Second International Conference on the Varicella-Zoster Virus, Paris, July 1994
20. 20. De Moragas JM, Kierland RR. The outcome of patients with herpes zoster. AMA Arch Dermatol 1957; 75: 193-6
21. 21. Raggozzino MW, Melton III LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine 1982; 61:310-6
22. 22. Dworkin RH, Banks SM. A vulnerability-diathesis-stress model of the pathogenesis of chronic pain: herpes zoster and the development of postherpetic neuralgia. In: Gatchel RJ, Turk DC, editors. Psychosocial factors in pain: evolution and revolutions. New York: Guilford, 1999: 247-69
23. 23. Satterthwaite JR. Postherpetic neuralgia. In: Tollison CD, editor. Handbook of chronic pain management. Baltimore: Williams & Wilkins, 1989: 460-74
24. 24. Schmader K. Management of herpes zoster in elderly patients. Infect Dis Clin Pract 1995; 4: 293-9
25. 25. Davies L, Cossins L, Bowsher D, et al. The cost of treatment for post-herpetic neuralgia in the UK. Pharmacoeconomics 1994; 6: 142-8
26. 26. Graff-Radford SB, Kames LD, Naliboff BD. Measures of psychological adjustment and perception of pain in postherpetic neuralgia and trigeminal neuralgia. Clin J Pain 1986; 2: 55-8
27. 27. Rowbotham MC, Petersen KL, Fields HL. Is postherpetic neuralgia more than one disorder? Pain Forum 1998; 7: 231-7
28. 28. Nathan PW, Wall PD. Treatment of postherpetic neuralgia by prolonged electrical stimulation. BMJ 1974; 3: 645-7
29. 29. Gerson GR, Jones RB, Luscombe DK. Studies of the concomitant use of carbamazepine and clomipramine for the relief of postherpetic neuralgia. Postgrad Med J 1977; 54 Suppl. 4: 104-9
30. 30. Payne C. Ultrasound for post-herpetic neuralgia. Physiotherapy 1984; 70: 96-7
31. 31. Jones RJ, Silman GM. Trials of ultrasonic therapy for acute herpes zoster. Practitioner 1987; 231: 1336-40
32. 32. Lewith GT, Field F, Machin D. Acupuncture versus placebo in postherpetic pain. Pain 1983; 17: 361-8
33. 33. Dung HC. Acupuncture for the treatment of post-herpetic neuralgia. Am J Acupunct 1987; 15: 5-14
34. 34. Volmink J, Lancaster T, Gray S, et al. Treatments for postherpetic neuralgia - a systematic review of randomized controlled trials. Fam Pract 1996; 13: 84-91
35. 35. McQuay HJ, Moore RA. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998
36. 36. Alexander JI. Postherpetic neuralgia. Anaesthesia 1985; 40: 1133-4
37. 37. Coniam SW, Hunton, J. A study of benzydamine cream in post-herpetic neuralgia. Res Clin Forums 1988; 10: 65-7
38. 38. McQuay HJ, Carroll D, Moxon A, et al. Benzydamine cream for the treatment of post-herpetic neuralgia: minimum duration of treatment periods in a cross-over trial. Pain 1990; 40: 131-5
39. 39. King RB. Concerning the management of pain associated with herpes zoster and of postherpetic neuralgia. Pain 1988; 33: 73-8
40. 40. Bowsher D, Gill H. Aspirin-in-chloroform for the topical treatment of postherpetic neuralgia. J Pain Soc Great Br Ireland 1991; 9: 16-7
41. 41. De Benedittis G, Besana F, Lorenzetti A. A new topical treatment for acute herpetic neuralgia and postherpetic neuralgia: the aspirin/diethyl ether mixture: an open-label study plus a double-blind, controlled clinical trial. Pain 1992; 48: 383-90
42. 42. King RB. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neural 1993; 88: 556-61
43. 43. Stow PJ, Glynn CJ, Minor B. EMLA cream in the treatment of postherpetic neuralgia: efficacy and pharmacokinetic profile. Pain 1989; 39: 301-5
44. 44. Collins PD. EMLA Cream and herpetic neuralgia. Med J Aust 1991; 155: 206-7
45. 45. Wheeler JG. EMLA cream and herpetic neuralgia. Med J Aust 1991; 154:781
46. 46. Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves post-herpetic neuralgia. Ann Neurol 1995; 37: 246-53
47. 47. Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65: 39-44
48. 48. Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999; 80: 533-8
49. 49. Max MB. Treatment of post-herpetic neuralgia: antidepres-sants. Ann Neurol 1994; 35 Suppl.: S50-3
50. 50. Watson CPN, Evans RJ, Reed K, et al. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671-3
51. 51. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990; 47:305-12
52. 52. Watson CPN, Evans RJ. A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia. Pain 1985; 23: 387-94
53. 53. Watson CPN, Chipman M, Reed K, et al. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992; 48: 29-36
54. 54. Watson CPN, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998; 51: 1166-71
55. 55. McQuay HJ, Tramer M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217-27
56. 56. Max MB. Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 1995; 4: 248-53
57. 57. Sindrup SH, Gram LF, Skjold T, et al. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther 1990; 47: 509-15
58. 58. Zitman FG, Linssen ACG, Edelbroek PM, et al. Low dose amitriptyline in chronic pain: the gain is modest. Pain 1990; 42, 35-42
59. 59. McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993; 48: 281-5
60. 60. Sindrup SH, Gram LF, Brøsen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain 1990; 42: 135-44
61. 61. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992; 52: 547-52
62. 62. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-6
63. 63. Lang E, Hord AH, Denson D. Venlafaxine hydrochloride (Effexor) relieves thermal hyperalgesia in rats with an experimental mononeuropathy. Pain 1996; 68: 151-5
64. 64. Taylor K, Rowbotham MC. Venlafaxine hydrochloride and chronic pain. West J Med 1996; 165: 147-8
65. 65. McQuay HJ, Carroll D, Jadad AR. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995; 311: 1047-52
66. 66. Watson CPN. The medical treatment of postherpetic neuralgia: antidepressants, other therapies, and practical guidelines for management. In: Watson CPN, editor. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993: 205-19
67. 67. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol 1968; 19: 129-36
68. 68. Hatangdi VS, Boas RA, Richards EG. Postherpetic neuralgia: management with antiepileptic and tricyclic drugs. In: Bonica JJ, Albe-Fessard D, editors. Advances in pain research and therapy, Vol. 1. New York: Raven, 1976: 583-7
69. 69. Raftery H. The management of postherpetic pain using sodium valproate and amitriptyline. Ir Med J 1979; 72: 399-401
70. 70. Rowbotham MC, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280: 1837-42
71. 71. Max MB, Schafer SC, Culnane M, et al. Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988; 43: 363-71
72. 72. Rowbotham MC, Reisner-Keller L, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-8
73. 73. Pappagallo M, Campbell JN. Chronic opioid therapy as alternative treatment for post-herpetic neuralgia. Ann Neurol 1994; 35 (Suppl.): S54-6
74. 74. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-41
75. 75. Raffa RB, Friderichs E, Reimann W, et al. Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275-85
76. 76. Göbel H, Stadier T. Treatment of pain due to postherpetic neuralgia with tramadol: results of an open, parallel pilot study vs clomipramine with and without levomepromazine. Clin Drug Invest 1995; 10:208-14
77. 77. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50: 1842-6
78. 78. Backonja M, Arndt G, Gombar KA. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994; 56: 51-7
79. 79. Eide PK, Jørum E, Stubhaug A, et al. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347-54
80. 80. Hoffmann VH, Coppejans H, Vercauteren M, et al. Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 1994; 10: 240-2
81. 81. Kato Y, Homma I, Ichiyanagi K. Postherpetic neuralgia. Pain 1995; 11: 336-7
82. 82. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind, randomised controlled crossover trial with integral n-of-I design. Pain 1994; 59: 127-33
83. 83. Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997,48: 1212-8
84. 84. Galbraith AW. Treatment of acute herpes zoster with amantadine hydrochloride (Symmetrel). BMJ 1973; 4: 693-5
85. 85. Eisenberg E, Pud D. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine? Pain 1998; 74: 337-9
86. 86. Whitney CW, Von Korff M. Regression to the mean in treated versus untreated chronic pain. Pain 1992; 50: 281-5
87. 87. Csillik B, Knyihar-Csillik E, Szucs A. Treatment of chronic pain syndromes with iontophoresis of vinca alkaloids to the skin of patients. Neuroscience 1982; 31: 87-90
88. 88. Ikebe H, Miyagawa A, Mizutani A, et al. The effect of iontophoresis with several Ca channel blockers for PHN patients. Masui 1995; 44: 428-33
89. 89. Reiestad F, Kvalheim L, McIlvaine WB. Pleural analgesia for the treatment of acute severe thoracic herpes zoster. Reg Anesth 1989; 14: 244-6
90. 90. Reiestad F, McIlvaine WB, Barnes M, et al. Interpleural analgesia in the treatment of severe thoracic postherpetic neuralgia. Reg Anesth 1990; 15: 113-7
91. 91. Thwaites BK, Powell DR. Interpleural block for acute combined cervical and thoracic herpes zoster. Reg Anesth 1995; 20: 255-6
92. 92. Fine PG. Nerve blocks, herpes zoster, and postherpetic neuralgia. In: Watson CPN, editor. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993: 173-83
93. 93. Wu CL, March A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain In press
94. 94. Milligan NS, Nash TP. Treatment of post-herpetic neuralgia: a review of 77 consecutive cases. Pain 1985; 23: 381-6
95. 95. Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of postherpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993; 18: 277-82
96. 96. Hogan QH. The sympathetic nervous system in post-herpetic neuralgia. Reg Anesth 1993; 18: 271-3
97. 97. Higa K. Acute herpetic pain and post-herpetic neuralgia. Eur J Pain 1993; 14: 79-90
98. 98. Dan K. Nerve block therapy and postherpetic neuralgia. Crit Rev Phys Rehab Med 1995; 7: 93-112
99. 99. Manabe H, Dan K, Higa K. Continuous epidural infusion of local anesthetics and shorter duration of acute zoster-associated pain. Clin J Pain 1995; 11: 220-8
100. 100. Kikuchi A, Kotani N, Sato T, et al. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable post-herpetic neuralgia. Reg Anesth Pain Med 1999; 24: 287-93
101. 101. Ahram SE. Intrathecal steroid injection for postherpetic neuralgia: what are the risks? Reg Anesth Pain Med 1999; 24: 283-5
102. 102. Dworkin RH, Hartstein G, Rosner HL, et al. A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 1992; 101:200-5
103. 103. Graff-Radford SB, Kames LD, Naliboff BD. Measures of psychological adjustment and perception of pain in postherpetic neuralgia and trigeminal neuralgia. Clin J Pain 1986; 2: 55-8
104. 104. Rose MJ, Klenerman L, Atchison L. An application of the fear avoidance model to three chronic pain conditions. Behav Res Ther 1992; 30:359-65
105. 105. Thomsen TC. Shingles and PHN. New York (NY): Cross River, 1994
106. 106. Turk DC, Meichenbaum D. Genest M. Pain and behavioral medicine: a cognitive-behavioral perspective. New York (NY): Guilford, 1983
107. 107. Gatchel RJ, Turk DC, editors. Psychological approaches to pain management: a practitioner's handbook. New York (NY): Guilford, 1996
108. 108. Loeser J. Surgery for postherpetic neuralgia. In: Watson CPN, editor. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier, 1993:221-37
109. 109. Johnson RW. The future of predictors, prevention, and therapy in postherpetic neuralgia. Neurology 1995; 45 Suppl. 8: S70-2
110. 110. Dworkin RH. Which individuals with acute pain are most likely to develop a chronic pain syndrome? Pain Forum 1997; 6: 127-36
111. 111. Dworkin RH. Prevention of postherpetic neuralgia. Lancet 1999; 353: 1636-7
112. 112. Wood MJ, Johnson RW, McKendrick MW, et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330: 896-900
113. 113. Whitley RJ, Weiss H, Jr Gnann JW, et al. Acvclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 1996; 125: 376-83
114. 114. Bowsher D. The effects of pre-emptive treatment of post-herpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Sympt Manage 1997; 13:327-31
115. 115. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain. In press
116. 116. Donohue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med 1995; 155: 1605-9
117. 117. Weller TH. Varicella and herpes zoster: a perspective and overview. J Infect Dis 1992; 166 Suppl. 1: Sl-6
118. 118. Johnson RW. Current and future management of herpes zoster. Antiviral Chem Chemother 1997; 8 Suppl. 1: 11-20
119. 119. Hayward A, Levin M, Wolf W. Varicella-zoster virus-specific immunity after herpes zoster. J Infect Dis 1991; 163: 873-5
120. 120. Oxman M. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45 Suppl. 8; S41-6
121. 121. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis 1998; 178 Suppl. 1:S109-12